Search
Protocol No.: EAY191-N5
- Title
- A Randomized Trial of Neratinib, A Pan-ErbB Inhibitor, Alone or in Combination with Palbociclib, A CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors - A ComboMATCH Treatment Trial
- Principal Investigator
- Almubarak, Mohammed
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Breast Cancer
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynecologic Cancers
- Head and Neck Cancers
- Lung Cancer
- Melanoma and Other Skin Cancers
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Rachel Harper
- Clinical Research Specialist
- Phone: +1 304-293-6066
- Email: rachel.harper@hsc.wvu.edu